{"users":[{"id":1,"username":"VitaDAO","name":"VitaDAO","avatar_template":"/user_avatar/gov.vitadao.com/vitadao/{size}/9_2.png","admin":true,"trust_level":4},{"id":49,"username":"NickVitaDAO","name":"Nick Fiorenza","avatar_template":"/user_avatar/gov.vitadao.com/nickvitadao/{size}/63_2.png","trust_level":2},{"id":674,"username":"animalsrnotfood","name":"Boris","avatar_template":"/user_avatar/gov.vitadao.com/animalsrnotfood/{size}/911_2.png","trust_level":1},{"id":24,"username":"alexdobrin","name":"Alex Dobrin","avatar_template":"/user_avatar/gov.vitadao.com/alexdobrin/{size}/198_2.png","trust_level":4},{"id":214,"username":"SB23","name":"Sebastian","avatar_template":"/user_avatar/gov.vitadao.com/sb23/{size}/207_2.png","trust_level":2},{"id":251,"username":"bowtiedshrike","name":"Bowtied Shrike","avatar_template":"/user_avatar/gov.vitadao.com/bowtiedshrike/{size}/227_2.png","trust_level":2},{"id":507,"username":"aschwartzphd","name":"Anthony Schwartz","avatar_template":"https://avatars.discourse-cdn.com/v4/letter/a/34f0e0/{size}.png","trust_level":2},{"id":389,"username":"mykalt45","name":"Michael","avatar_template":"/user_avatar/gov.vitadao.com/mykalt45/{size}/565_2.png","trust_level":2},{"id":947,"username":"marco0808","name":null,"avatar_template":"https://avatars.discourse-cdn.com/v4/letter/m/da6949/{size}.png","trust_level":0},{"id":43,"username":"Taliskermalt","name":"Todd White","avatar_template":"/user_avatar/gov.vitadao.com/taliskermalt/{size}/62_2.png","trust_level":2},{"id":858,"username":"Vita","name":"","avatar_template":"https://avatars.discourse-cdn.com/v4/letter/v/51bf81/{size}.png","trust_level":0},{"id":940,"username":"8RoaringLion8","name":null,"avatar_template":"https://avatars.discourse-cdn.com/v4/letter/8/82dd89/{size}.png","trust_level":0},{"id":944,"username":"roneylaurent","name":"Roney Laurent","avatar_template":"/user_avatar/gov.vitadao.com/roneylaurent/{size}/1064_2.png","trust_level":1},{"id":916,"username":"Joesatan","name":"DAO@vita0001","avatar_template":"https://avatars.discourse-cdn.com/v4/letter/j/839c29/{size}.png","trust_level":1},{"id":914,"username":"Punith","name":"Punith","avatar_template":"https://avatars.discourse-cdn.com/v4/letter/p/a6a055/{size}.png","trust_level":0},{"id":181,"username":"Paolo","name":"Paolo Binetti","avatar_template":"/user_avatar/gov.vitadao.com/paolo/{size}/262_2.png","moderator":true,"trust_level":2},{"id":853,"username":"Suhail","name":"","avatar_template":"/user_avatar/gov.vitadao.com/suhail/{size}/1005_2.png","trust_level":1},{"id":686,"username":"Lorna_Harries","name":"Lorna Harries","avatar_template":"https://avatars.discourse-cdn.com/v4/letter/l/ebca7d/{size}.png","trust_level":1},{"id":23,"username":"longevion","name":"Laurence Ion","avatar_template":"/user_avatar/gov.vitadao.com/longevion/{size}/675_2.png","trust_level":4},{"id":557,"username":"michele.gallia","name":"Michele Gallia","avatar_template":"https://avatars.discourse-cdn.com/v4/letter/m/c37758/{size}.png","trust_level":2},{"id":884,"username":"walker","name":"Walker","avatar_template":"https://avatars.discourse-cdn.com/v4/letter/w/d26b3c/{size}.png","trust_level":1},{"id":845,"username":"Dmitriy4pro","name":"DIma","avatar_template":"https://avatars.discourse-cdn.com/v4/letter/d/f9ae1b/{size}.png","trust_level":1},{"id":837,"username":"topvalue","name":"Yousoo Kim","avatar_template":"/user_avatar/gov.vitadao.com/topvalue/{size}/1003_2.png","trust_level":2},{"id":793,"username":"Arexihul","name":null,"avatar_template":"https://avatars.discourse-cdn.com/v4/letter/a/87869e/{size}.png","trust_level":0},{"id":810,"username":"Rudy","name":"Rudy","avatar_template":"https://avatars.discourse-cdn.com/v4/letter/r/5fc32e/{size}.png","trust_level":0},{"id":748,"username":"Len","name":"Len","avatar_template":"https://avatars.discourse-cdn.com/v4/letter/l/58f4c7/{size}.png","trust_level":1},{"id":16,"username":"vincent","name":"Vincent","avatar_template":"/user_avatar/gov.vitadao.com/vincent/{size}/93_2.png","moderator":true,"trust_level":4},{"id":459,"username":"gweisha","name":"Eleanor Davies","avatar_template":"/user_avatar/gov.vitadao.com/gweisha/{size}/700_2.png","trust_level":3},{"id":744,"username":"Gorda.eth","name":"Brenda","avatar_template":"/user_avatar/gov.vitadao.com/gorda.eth/{size}/982_2.png","trust_level":1},{"id":218,"username":"rpill","name":"","avatar_template":"/user_avatar/gov.vitadao.com/rpill/{size}/979_2.png","trust_level":2},{"id":13,"username":"timrpeterson","name":"Tim Peterson","avatar_template":"/user_avatar/gov.vitadao.com/timrpeterson/{size}/19_2.png","trust_level":2},{"id":211,"username":"benji","name":"Benji Leibowitz","avatar_template":"/user_avatar/gov.vitadao.com/benji/{size}/655_2.png","moderator":true,"trust_level":2},{"id":241,"username":"philip_rhoades","name":"Philip Rhoades","avatar_template":"/user_avatar/gov.vitadao.com/philip_rhoades/{size}/223_2.png","trust_level":1},{"id":722,"username":"DanilaImmortalist","name":"Danila Immortalist","avatar_template":"/user_avatar/gov.vitadao.com/danilaimmortalist/{size}/963_2.png","trust_level":1},{"id":189,"username":"LifeofDan-EL","name":"Daniel  Anomfueme","avatar_template":"/user_avatar/gov.vitadao.com/lifeofdan-el/{size}/289_2.png","trust_level":2},{"id":711,"username":"Sunny","name":"sam","avatar_template":"/user_avatar/gov.vitadao.com/sunny/{size}/949_2.png","trust_level":0},{"id":76,"username":"schmackofant","name":"","avatar_template":"/user_avatar/gov.vitadao.com/schmackofant/{size}/82_2.png","trust_level":2},{"id":704,"username":"alexm","name":"Alex M","avatar_template":"/user_avatar/gov.vitadao.com/alexm/{size}/947_2.png","trust_level":1},{"id":272,"username":"SimiKol","name":"Pg","avatar_template":"https://avatars.discourse-cdn.com/v4/letter/s/e79b87/{size}.png","trust_level":2},{"id":347,"username":"clarck7","name":"clarkwang","avatar_template":"/user_avatar/gov.vitadao.com/clarck7/{size}/346_2.png","trust_level":2},{"id":468,"username":"Shift","name":"Shift","avatar_template":"/user_avatar/gov.vitadao.com/shift/{size}/559_2.png","trust_level":2},{"id":680,"username":"alanduranfire","name":"","avatar_template":"https://avatars.discourse-cdn.com/v4/letter/a/e47c2d/{size}.png","trust_level":0},{"id":281,"username":"Rhys","name":"Rhys","avatar_template":"https://avatars.discourse-cdn.com/v4/letter/r/db5fbb/{size}.png","trust_level":2},{"id":654,"username":"ADMelhede","name":"Andreas Melhede","avatar_template":"/user_avatar/gov.vitadao.com/admelhede/{size}/892_2.png","trust_level":2},{"id":35,"username":"Max_Unfried","name":"","avatar_template":"https://avatars.discourse-cdn.com/v4/letter/m/f0a364/{size}.png","trust_level":2},{"id":294,"username":"rdspang","name":"Ryan Spangler","avatar_template":"https://avatars.discourse-cdn.com/v4/letter/r/35a633/{size}.png","trust_level":1},{"id":144,"username":"m_marinova","name":"Maria Marinova","avatar_template":"https://avatars.discourse-cdn.com/v4/letter/m/cab0a1/{size}.png","moderator":true,"trust_level":3},{"id":659,"username":"Shahaf","name":"Shahaf Peleg","avatar_template":"https://avatars.discourse-cdn.com/v4/letter/s/47e85d/{size}.png","trust_level":1}],"primary_groups":[],"flair_groups":[],"topic_list":{"can_create_topic":false,"filter":"latest","more_topics_url":"/c/proposals/11?page=1","per_page":30,"topics":[{"fancy_title":"About the Proposals Category","id":18,"title":"About the Proposals Category","slug":"about-the-proposals-category","posts_count":3,"reply_count":1,"highest_post_number":3,"image_url":null,"created_at":"2021-05-03T13:53:04.559Z","last_posted_at":"2024-03-15T02:07:16.982Z","bumped":true,"bumped_at":"2024-03-15T02:07:16.982Z","archetype":"regular","unseen":false,"pinned":true,"unpinned":null,"excerpt":"The proposals category is the place to discuss formal proposals on which VitaDAO members (you) will vote, on chain. \nBefore the proposal goes to member vote, we’ll discuss and refine it. The final version, once locked he…","visible":true,"closed":false,"archived":false,"bookmarked":null,"liked":null,"views":899,"like_count":5,"has_summary":false,"last_poster_username":"animalsrnotfood","category_id":11,"op_like_count":3,"pinned_globally":false,"featured_link":null,"has_accepted_answer":false,"posters":[{"extras":null,"description":"Original Poster","user_id":1,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Recent Poster","user_id":49,"primary_group_id":null,"flair_group_id":null},{"extras":"latest","description":"Most Recent Poster","user_id":674,"primary_group_id":null,"flair_group_id":null}]},{"fancy_title":"VDP-164 VitaDAO Funding Proposal: $500K Loan to Advance VITARNA Through Non-GLP Toxicology Toward 2026 IND Submission","id":2052,"title":"VDP-164 VitaDAO Funding Proposal: $500K Loan to Advance VITARNA Through Non-GLP Toxicology Toward 2026 IND Submission","slug":"vdp-164-vitadao-funding-proposal-500k-loan-to-advance-vitarna-through-non-glp-toxicology-toward-2026-ind-submission","posts_count":17,"reply_count":8,"highest_post_number":18,"image_url":"https://europe1.discourse-cdn.com/flex017/uploads/vitadao/original/2X/5/56bf46d91d89d43c75b21a79ff028b8c76e75439.png","created_at":"2025-09-16T22:09:12.831Z","last_posted_at":"2026-03-03T14:32:26.632Z","bumped":true,"bumped_at":"2026-03-03T14:32:26.632Z","archetype":"regular","unseen":false,"pinned":false,"unpinned":null,"visible":true,"closed":false,"archived":false,"bookmarked":null,"liked":null,"views":710,"like_count":10,"has_summary":false,"last_poster_username":"alexdobrin","category_id":11,"op_like_count":0,"pinned_globally":false,"featured_link":null,"has_accepted_answer":false,"posters":[{"extras":"latest","description":"Original Poster, Most Recent Poster","user_id":24,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Frequent Poster","user_id":214,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Frequent Poster","user_id":251,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Recent Poster","user_id":507,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Recent Poster","user_id":389,"primary_group_id":null,"flair_group_id":null}]},{"fancy_title":"Seeking Feedback: A New Tool to Prevent Crypto Transfer Mistakes","id":2095,"title":"Seeking Feedback: A New Tool to Prevent Crypto Transfer Mistakes","slug":"seeking-feedback-a-new-tool-to-prevent-crypto-transfer-mistakes","posts_count":1,"reply_count":0,"highest_post_number":1,"image_url":null,"created_at":"2026-02-13T14:41:45.870Z","last_posted_at":"2026-02-13T14:41:45.917Z","bumped":true,"bumped_at":"2026-02-13T14:41:45.917Z","archetype":"regular","unseen":false,"pinned":false,"unpinned":null,"visible":true,"closed":false,"archived":false,"bookmarked":null,"liked":null,"views":43,"like_count":0,"has_summary":false,"last_poster_username":"marco0808","category_id":13,"op_like_count":0,"pinned_globally":false,"featured_link":null,"has_accepted_answer":false,"posters":[{"extras":"latest single","description":"Original Poster, Most Recent Poster","user_id":947,"primary_group_id":null,"flair_group_id":null}]},{"fancy_title":"VDP-161.1: BIO Token Airdrop to VitaDAO Community (Improvement Proposal to VDP-161)","id":1925,"title":"VDP-161.1: BIO Token Airdrop to VitaDAO Community (Improvement Proposal to VDP-161)","slug":"vdp-161-1-bio-token-airdrop-to-vitadao-community-improvement-proposal-to-vdp-161","posts_count":8,"reply_count":2,"highest_post_number":8,"image_url":null,"created_at":"2025-01-17T08:32:00.535Z","last_posted_at":"2026-01-27T00:46:45.153Z","bumped":true,"bumped_at":"2026-01-27T00:46:45.153Z","archetype":"regular","unseen":false,"pinned":false,"unpinned":null,"visible":true,"closed":false,"archived":false,"bookmarked":null,"liked":null,"views":711,"like_count":20,"has_summary":false,"last_poster_username":"roneylaurent","category_id":11,"op_like_count":4,"pinned_globally":false,"featured_link":null,"has_accepted_answer":false,"posters":[{"extras":null,"description":"Original Poster","user_id":24,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Frequent Poster","user_id":43,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Frequent Poster","user_id":858,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Recent Poster","user_id":940,"primary_group_id":null,"flair_group_id":null},{"extras":"latest","description":"Most Recent Poster","user_id":944,"primary_group_id":null,"flair_group_id":null}]},{"fancy_title":"Unfair Ban from Discord Server","id":2056,"title":"Unfair Ban from Discord Server","slug":"unfair-ban-from-discord-server","posts_count":2,"reply_count":0,"highest_post_number":2,"image_url":null,"created_at":"2025-09-20T01:10:15.025Z","last_posted_at":"2025-09-20T11:02:59.023Z","bumped":true,"bumped_at":"2025-09-20T11:02:59.023Z","archetype":"regular","unseen":false,"pinned":false,"unpinned":null,"visible":true,"closed":false,"archived":false,"bookmarked":null,"liked":null,"views":120,"like_count":0,"has_summary":false,"last_poster_username":"Joesatan","category_id":14,"op_like_count":0,"pinned_globally":false,"featured_link":null,"has_accepted_answer":false,"posters":[{"extras":"latest single","description":"Original Poster, Most Recent Poster","user_id":916,"primary_group_id":null,"flair_group_id":null}]},{"fancy_title":"Enhancing Researcher Verification and Dispute Resolution in VitaDAO","id":2049,"title":"Enhancing Researcher Verification and Dispute Resolution in VitaDAO","slug":"enhancing-researcher-verification-and-dispute-resolution-in-vitadao","posts_count":2,"reply_count":0,"highest_post_number":2,"image_url":null,"created_at":"2025-08-27T06:58:38.007Z","last_posted_at":"2025-09-07T05:04:28.597Z","bumped":true,"bumped_at":"2025-09-07T05:04:28.597Z","archetype":"regular","unseen":false,"pinned":false,"unpinned":null,"visible":true,"closed":false,"archived":false,"bookmarked":null,"liked":null,"views":113,"like_count":3,"has_summary":false,"last_poster_username":"bowtiedshrike","category_id":14,"op_like_count":2,"pinned_globally":false,"featured_link":null,"has_accepted_answer":false,"posters":[{"extras":null,"description":"Original Poster","user_id":914,"primary_group_id":null,"flair_group_id":null},{"extras":"latest","description":"Most Recent Poster","user_id":251,"primary_group_id":null,"flair_group_id":null}]},{"fancy_title":"VDP-163 [Funding] FOXO3 oligos - Revised","id":2033,"title":"VDP-163 [Funding] FOXO3 oligos - Revised","slug":"vdp-163-funding-foxo3-oligos-revised","posts_count":6,"reply_count":2,"highest_post_number":6,"image_url":"https://europe1.discourse-cdn.com/flex017/uploads/vitadao/optimized/2X/2/2fc78f7b3ad1d52d81550856e249f26ae89c1de7_2_1024x453.png","created_at":"2025-08-01T23:36:19.559Z","last_posted_at":"2025-08-19T21:02:23.596Z","bumped":true,"bumped_at":"2025-08-19T21:02:23.596Z","archetype":"regular","unseen":false,"pinned":false,"unpinned":null,"visible":true,"closed":false,"archived":false,"bookmarked":null,"liked":null,"views":609,"like_count":9,"has_summary":false,"last_poster_username":"Lorna_Harries","category_id":11,"op_like_count":1,"pinned_globally":false,"featured_link":null,"has_accepted_answer":false,"posters":[{"extras":null,"description":"Original Poster","user_id":181,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Frequent Poster","user_id":251,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Recent Poster","user_id":853,"primary_group_id":null,"flair_group_id":null},{"extras":"latest","description":"Most Recent Poster","user_id":686,"primary_group_id":null,"flair_group_id":null}]},{"fancy_title":"VDP-162 [Funding] Virtual Cell Foundation Model for Longevity Research","id":1970,"title":"VDP-162 [Funding] Virtual Cell Foundation Model for Longevity Research","slug":"vdp-162-funding-virtual-cell-foundation-model-for-longevity-research","posts_count":7,"reply_count":2,"highest_post_number":9,"image_url":null,"created_at":"2025-02-26T13:56:53.973Z","last_posted_at":"2025-05-12T02:38:23.182Z","bumped":true,"bumped_at":"2025-05-12T02:38:53.127Z","archetype":"regular","unseen":false,"pinned":false,"unpinned":null,"visible":true,"closed":false,"archived":false,"bookmarked":null,"liked":null,"views":567,"like_count":21,"has_summary":false,"last_poster_username":"walker","category_id":14,"op_like_count":6,"pinned_globally":false,"featured_link":null,"has_accepted_answer":false,"posters":[{"extras":null,"description":"Original Poster","user_id":24,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Frequent Poster","user_id":23,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Frequent Poster","user_id":557,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Recent Poster","user_id":251,"primary_group_id":null,"flair_group_id":null},{"extras":"latest","description":"Most Recent Poster","user_id":884,"primary_group_id":null,"flair_group_id":null}]},{"fancy_title":"Proposal to Manage VitaDAO’s Social Media Accounts","id":1945,"title":"Proposal to Manage VitaDAO’s Social Media Accounts","slug":"proposal-to-manage-vitadao-s-social-media-accounts","posts_count":4,"reply_count":2,"highest_post_number":4,"image_url":null,"created_at":"2025-01-25T16:27:10.380Z","last_posted_at":"2025-03-15T18:51:54.306Z","bumped":true,"bumped_at":"2025-03-15T18:51:54.306Z","archetype":"regular","unseen":false,"pinned":false,"unpinned":null,"visible":true,"closed":false,"archived":false,"bookmarked":null,"liked":null,"views":223,"like_count":9,"has_summary":false,"last_poster_username":"Suhail","category_id":14,"op_like_count":3,"pinned_globally":false,"featured_link":null,"has_accepted_answer":false,"posters":[{"extras":"latest","description":"Original Poster, Most Recent Poster","user_id":853,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Recent Poster","user_id":24,"primary_group_id":null,"flair_group_id":null}]},{"fancy_title":"VDP-156: Develop and Launch VItamycin for VitaDAO Token Holders","id":1730,"title":"VDP-156: Develop and Launch VItamycin for VitaDAO Token Holders","slug":"vdp-156-develop-and-launch-vitamycin-for-vitadao-token-holders","posts_count":21,"reply_count":10,"highest_post_number":23,"image_url":null,"created_at":"2024-08-21T15:52:55.236Z","last_posted_at":"2025-02-12T11:06:56.060Z","bumped":true,"bumped_at":"2025-02-12T11:06:56.060Z","archetype":"regular","unseen":false,"pinned":false,"unpinned":null,"visible":true,"closed":true,"archived":false,"bookmarked":null,"liked":null,"views":804,"like_count":35,"has_summary":false,"last_poster_username":"Dmitriy4pro","category_id":11,"op_like_count":1,"pinned_globally":false,"featured_link":null,"has_accepted_answer":false,"posters":[{"extras":null,"description":"Original Poster","user_id":24,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Frequent Poster","user_id":251,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Frequent Poster","user_id":389,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Recent Poster","user_id":1,"primary_group_id":null,"flair_group_id":null},{"extras":"latest","description":"Most Recent Poster","user_id":845,"primary_group_id":null,"flair_group_id":null}]},{"fancy_title":"VDP-161: BIO Token Airdrop to VitaDAO Community","id":1755,"title":"VDP-161: BIO Token Airdrop to VitaDAO Community","slug":"vdp-161-bio-token-airdrop-to-vitadao-community","posts_count":9,"reply_count":1,"highest_post_number":12,"image_url":null,"created_at":"2024-12-23T17:49:57.328Z","last_posted_at":"2025-01-03T15:00:12.485Z","bumped":true,"bumped_at":"2025-01-03T15:00:12.485Z","archetype":"regular","unseen":false,"pinned":false,"unpinned":null,"visible":true,"closed":true,"archived":false,"bookmarked":null,"liked":null,"views":2263,"like_count":36,"has_summary":false,"last_poster_username":"Rudy","category_id":11,"op_like_count":15,"pinned_globally":false,"featured_link":null,"has_accepted_answer":false,"posters":[{"extras":null,"description":"Original Poster","user_id":24,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Frequent Poster","user_id":1,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Frequent Poster","user_id":837,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Recent Poster","user_id":793,"primary_group_id":null,"flair_group_id":null},{"extras":"latest","description":"Most Recent Poster","user_id":810,"primary_group_id":null,"flair_group_id":null}]},{"fancy_title":"VDP-159: Bridge VITA to Solana","id":1754,"title":"VDP-159: Bridge VITA to Solana","slug":"vdp-159-bridge-vita-to-solana","posts_count":3,"reply_count":0,"highest_post_number":3,"image_url":null,"created_at":"2024-12-23T17:49:07.746Z","last_posted_at":"2025-01-01T10:22:13.399Z","bumped":true,"bumped_at":"2025-01-01T10:22:13.399Z","archetype":"regular","unseen":false,"pinned":false,"unpinned":null,"visible":true,"closed":true,"archived":false,"bookmarked":null,"liked":null,"views":871,"like_count":7,"has_summary":false,"last_poster_username":"topvalue","category_id":11,"op_like_count":3,"pinned_globally":false,"featured_link":null,"has_accepted_answer":false,"posters":[{"extras":null,"description":"Original Poster","user_id":24,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Frequent Poster","user_id":748,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Recent Poster","user_id":1,"primary_group_id":null,"flair_group_id":null},{"extras":"latest","description":"Most Recent Poster","user_id":837,"primary_group_id":null,"flair_group_id":null}]},{"fancy_title":"VitaDAO Delegate Applications - Apply now!","id":1401,"title":"VitaDAO Delegate Applications - Apply now!","slug":"vitadao-delegate-applications-apply-now","posts_count":18,"reply_count":2,"highest_post_number":19,"image_url":null,"created_at":"2023-08-08T16:21:13.031Z","last_posted_at":"2024-12-26T23:10:34.982Z","bumped":true,"bumped_at":"2024-12-26T23:10:34.982Z","archetype":"regular","unseen":false,"pinned":false,"unpinned":null,"visible":true,"closed":false,"archived":false,"bookmarked":null,"liked":null,"views":2052,"like_count":110,"has_summary":false,"last_poster_username":"Gorda.eth","category_id":11,"op_like_count":7,"pinned_globally":false,"featured_link":null,"has_accepted_answer":false,"posters":[{"extras":null,"description":"Original Poster","user_id":16,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Frequent Poster","user_id":24,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Frequent Poster","user_id":459,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Recent Poster","user_id":181,"primary_group_id":null,"flair_group_id":null},{"extras":"latest","description":"Most Recent Poster","user_id":744,"primary_group_id":null,"flair_group_id":null}]},{"fancy_title":"VDP-160: Vitality Now Association Setup – The New Legal Steward for VitaDAO","id":1753,"title":"VDP-160: Vitality Now Association Setup – The New Legal Steward for VitaDAO","slug":"vdp-160-vitality-now-association-setup-the-new-legal-steward-for-vitadao","posts_count":2,"reply_count":0,"highest_post_number":2,"image_url":null,"created_at":"2024-12-23T17:47:49.064Z","last_posted_at":"2024-12-25T01:11:25.721Z","bumped":true,"bumped_at":"2024-12-25T01:11:25.721Z","archetype":"regular","unseen":false,"pinned":false,"unpinned":null,"visible":true,"closed":true,"archived":false,"bookmarked":null,"liked":null,"views":278,"like_count":1,"has_summary":false,"last_poster_username":"Len","category_id":11,"op_like_count":1,"pinned_globally":false,"featured_link":null,"has_accepted_answer":false,"posters":[{"extras":null,"description":"Original Poster","user_id":24,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Recent Poster","user_id":1,"primary_group_id":null,"flair_group_id":null},{"extras":"latest","description":"Most Recent Poster","user_id":748,"primary_group_id":null,"flair_group_id":null}]},{"fancy_title":"VDP-158: Partnership with LEV Foundation for the RMR2 Mouse Rejuvenation Project","id":1748,"title":"VDP-158: Partnership with LEV Foundation for the RMR2 Mouse Rejuvenation Project","slug":"vdp-158-partnership-with-lev-foundation-for-the-rmr2-mouse-rejuvenation-project","posts_count":6,"reply_count":3,"highest_post_number":6,"image_url":null,"created_at":"2024-11-26T15:53:25.386Z","last_posted_at":"2024-11-30T02:58:54.393Z","bumped":true,"bumped_at":"2024-11-30T02:58:54.393Z","archetype":"regular","unseen":false,"pinned":false,"unpinned":null,"visible":true,"closed":true,"archived":false,"bookmarked":null,"liked":null,"views":308,"like_count":8,"has_summary":false,"last_poster_username":"bowtiedshrike","category_id":11,"op_like_count":0,"pinned_globally":false,"featured_link":null,"has_accepted_answer":false,"posters":[{"extras":null,"description":"Original Poster","user_id":24,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Frequent Poster","user_id":218,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Frequent Poster","user_id":13,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Recent Poster","user_id":1,"primary_group_id":null,"flair_group_id":null},{"extras":"latest","description":"Most Recent Poster","user_id":251,"primary_group_id":null,"flair_group_id":null}]},{"fancy_title":"VDP-157: Develop VitaDAO’s first longevity product","id":1740,"title":"VDP-157: Develop VitaDAO’s first longevity product","slug":"vdp-157-develop-vitadao-s-first-longevity-product","posts_count":8,"reply_count":5,"highest_post_number":8,"image_url":null,"created_at":"2024-10-17T17:33:57.748Z","last_posted_at":"2024-10-22T10:58:48.326Z","bumped":true,"bumped_at":"2024-10-22T10:58:48.326Z","archetype":"regular","unseen":false,"pinned":false,"unpinned":null,"visible":true,"closed":true,"archived":false,"bookmarked":null,"liked":null,"views":627,"like_count":5,"has_summary":false,"last_poster_username":"benji","category_id":11,"op_like_count":1,"pinned_globally":false,"featured_link":null,"has_accepted_answer":false,"posters":[{"extras":"latest","description":"Original Poster, Most Recent Poster","user_id":211,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Frequent Poster","user_id":241,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Recent Poster","user_id":1,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Recent Poster","user_id":251,"primary_group_id":null,"flair_group_id":null}]},{"fancy_title":"VDP 154 - Designate VitaDAO as a Vitalist Organization","id":1719,"title":"VDP 154 - Designate VitaDAO as a Vitalist Organization","slug":"vdp-154-designate-vitadao-as-a-vitalist-organization","posts_count":5,"reply_count":0,"highest_post_number":5,"image_url":null,"created_at":"2024-08-03T14:17:36.476Z","last_posted_at":"2024-08-07T16:26:32.161Z","bumped":true,"bumped_at":"2024-08-13T15:27:42.394Z","archetype":"regular","unseen":false,"pinned":false,"unpinned":null,"visible":true,"closed":true,"archived":false,"bookmarked":null,"liked":null,"views":223,"like_count":7,"has_summary":false,"last_poster_username":"LifeofDan-EL","category_id":13,"op_like_count":1,"pinned_globally":false,"featured_link":null,"has_accepted_answer":false,"posters":[{"extras":null,"description":"Original Poster","user_id":24,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Frequent Poster","user_id":557,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Frequent Poster","user_id":722,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Recent Poster","user_id":1,"primary_group_id":null,"flair_group_id":null},{"extras":"latest","description":"Most Recent Poster","user_id":189,"primary_group_id":null,"flair_group_id":null}]},{"fancy_title":"VDP-153 [Funding] Project Ab4AD","id":1710,"title":"VDP-153 [Funding] Project Ab4AD","slug":"vdp-153-funding-project-ab4ad","posts_count":4,"reply_count":0,"highest_post_number":4,"image_url":"https://europe1.discourse-cdn.com/flex017/uploads/vitadao/optimized/1X/2c796f98e0a7ad878cce71f481928fae5d9c14cc_2_1024x599.jpeg","created_at":"2024-07-24T02:46:34.679Z","last_posted_at":"2024-08-05T15:36:01.098Z","bumped":true,"bumped_at":"2024-08-05T17:22:37.916Z","archetype":"regular","unseen":false,"pinned":false,"unpinned":null,"visible":true,"closed":true,"archived":false,"bookmarked":null,"liked":null,"views":320,"like_count":7,"has_summary":false,"last_poster_username":"michele.gallia","category_id":11,"op_like_count":2,"pinned_globally":false,"featured_link":null,"has_accepted_answer":false,"posters":[{"extras":null,"description":"Original Poster","user_id":211,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Frequent Poster","user_id":251,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Frequent Poster","user_id":181,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Recent Poster","user_id":1,"primary_group_id":null,"flair_group_id":null},{"extras":"latest","description":"Most Recent Poster","user_id":557,"primary_group_id":null,"flair_group_id":null}]},{"fancy_title":"VDP-152 [Funding] Project TransFidelity","id":1702,"title":"VDP-152 [Funding] Project TransFidelity","slug":"vdp-152-funding-project-transfidelity","posts_count":22,"reply_count":15,"highest_post_number":22,"image_url":"https://europe1.discourse-cdn.com/flex017/uploads/vitadao/optimized/1X/d5891dd4a9fcfd5d879f6578cac222057f6e3933_2_1024x619.png","created_at":"2024-07-19T13:57:35.357Z","last_posted_at":"2024-08-02T20:02:36.364Z","bumped":true,"bumped_at":"2024-08-02T20:02:36.364Z","archetype":"regular","unseen":false,"pinned":false,"unpinned":null,"visible":true,"closed":true,"archived":false,"bookmarked":null,"liked":null,"views":791,"like_count":42,"has_summary":false,"last_poster_username":"benji","category_id":11,"op_like_count":3,"pinned_globally":false,"featured_link":null,"has_accepted_answer":false,"posters":[{"extras":"latest","description":"Original Poster, Most Recent Poster","user_id":211,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Frequent Poster","user_id":557,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Frequent Poster","user_id":251,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Recent Poster","user_id":1,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Recent Poster","user_id":181,"primary_group_id":null,"flair_group_id":null}]},{"fancy_title":"Could Someone Give me Advice on Community Governance Mechanisms for DAO Growth?","id":1714,"title":"Could Someone Give me Advice on Community Governance Mechanisms for DAO Growth?","slug":"could-someone-give-me-advice-on-community-governance-mechanisms-for-dao-growth","posts_count":2,"reply_count":0,"highest_post_number":2,"image_url":null,"created_at":"2024-07-29T06:17:41.493Z","last_posted_at":"2024-07-29T19:29:06.099Z","bumped":true,"bumped_at":"2024-07-29T19:29:06.099Z","archetype":"regular","unseen":false,"pinned":false,"unpinned":null,"visible":true,"closed":false,"archived":false,"bookmarked":null,"liked":null,"views":90,"like_count":3,"has_summary":false,"last_poster_username":"bowtiedshrike","category_id":13,"op_like_count":1,"pinned_globally":false,"featured_link":null,"has_accepted_answer":false,"posters":[{"extras":null,"description":"Original Poster","user_id":711,"primary_group_id":null,"flair_group_id":null},{"extras":"latest","description":"Most Recent Poster","user_id":251,"primary_group_id":null,"flair_group_id":null}]},{"fancy_title":"VDP-148 Blueprint for Sustainable Growth: Operationalizing VitaDAO’s New Mandate","id":1689,"title":"VDP-148 Blueprint for Sustainable Growth: Operationalizing VitaDAO’s New Mandate","slug":"vdp-148-blueprint-for-sustainable-growth-operationalizing-vitadao-s-new-mandate","posts_count":16,"reply_count":8,"highest_post_number":17,"image_url":"https://europe1.discourse-cdn.com/flex017/uploads/vitadao/original/1X/6e95226d5f0f6206336031510f75c4817f460c35.png","created_at":"2024-06-14T07:52:48.135Z","last_posted_at":"2024-06-22T18:06:59.912Z","bumped":true,"bumped_at":"2024-06-22T18:06:59.912Z","archetype":"regular","unseen":false,"pinned":false,"unpinned":null,"visible":true,"closed":true,"archived":false,"bookmarked":null,"liked":null,"views":1901,"like_count":59,"has_summary":false,"last_poster_username":"vincent","category_id":14,"op_like_count":2,"pinned_globally":false,"featured_link":null,"has_accepted_answer":false,"posters":[{"extras":null,"description":"Original Poster","user_id":24,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Frequent Poster","user_id":76,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Frequent Poster","user_id":704,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Recent Poster","user_id":1,"primary_group_id":null,"flair_group_id":null},{"extras":"latest","description":"Most Recent Poster","user_id":16,"primary_group_id":null,"flair_group_id":null}]},{"fancy_title":"VDP-146 [Funding] The development of oligonucleotide drugs for healthspan","id":1653,"title":"VDP-146 [Funding] The development of oligonucleotide drugs for healthspan","slug":"vdp-146-funding-the-development-of-oligonucleotide-drugs-for-healthspan","posts_count":20,"reply_count":11,"highest_post_number":20,"image_url":"https://europe1.discourse-cdn.com/flex017/uploads/vitadao/original/1X/363d95126cb8d1d3027882094e951e6bf6d100a5.png","created_at":"2024-04-23T19:18:45.863Z","last_posted_at":"2024-06-08T01:05:11.914Z","bumped":true,"bumped_at":"2024-06-08T01:05:11.914Z","archetype":"regular","unseen":false,"pinned":false,"unpinned":null,"visible":true,"closed":false,"archived":false,"bookmarked":null,"liked":null,"views":1295,"like_count":41,"has_summary":false,"last_poster_username":"bowtiedshrike","category_id":11,"op_like_count":7,"pinned_globally":false,"featured_link":null,"has_accepted_answer":false,"posters":[{"extras":null,"description":"Original Poster","user_id":459,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Frequent Poster","user_id":686,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Frequent Poster","user_id":557,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Recent Poster","user_id":272,"primary_group_id":null,"flair_group_id":null},{"extras":"latest","description":"Most Recent Poster","user_id":251,"primary_group_id":null,"flair_group_id":null}]},{"fancy_title":"Australian projects?","id":1683,"title":"Australian projects?","slug":"australian-projects","posts_count":1,"reply_count":0,"highest_post_number":1,"image_url":null,"created_at":"2024-06-02T23:58:11.236Z","last_posted_at":"2024-06-02T23:58:11.295Z","bumped":true,"bumped_at":"2024-06-02T23:58:11.295Z","archetype":"regular","unseen":false,"pinned":false,"unpinned":null,"visible":true,"closed":false,"archived":false,"bookmarked":null,"liked":null,"views":156,"like_count":0,"has_summary":false,"last_poster_username":"philip_rhoades","category_id":13,"op_like_count":0,"pinned_globally":false,"featured_link":null,"has_accepted_answer":false,"posters":[{"extras":"latest single","description":"Original Poster, Most Recent Poster","user_id":241,"primary_group_id":null,"flair_group_id":null}]},{"fancy_title":"VDP-147: Catalyst Beta Program: Funding Experiment for Longevity Research Moonshots","id":1672,"title":"VDP-147: Catalyst Beta Program: Funding Experiment for Longevity Research Moonshots","slug":"vdp-147-catalyst-beta-program-funding-experiment-for-longevity-research-moonshots","posts_count":14,"reply_count":5,"highest_post_number":14,"image_url":null,"created_at":"2024-05-18T14:57:49.227Z","last_posted_at":"2024-05-28T14:18:39.559Z","bumped":true,"bumped_at":"2024-05-28T14:18:39.559Z","archetype":"regular","unseen":false,"pinned":false,"unpinned":null,"visible":true,"closed":true,"archived":false,"bookmarked":null,"liked":null,"views":562,"like_count":48,"has_summary":false,"last_poster_username":"michele.gallia","category_id":14,"op_like_count":2,"pinned_globally":false,"featured_link":null,"has_accepted_answer":false,"posters":[{"extras":null,"description":"Original Poster","user_id":24,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Frequent Poster","user_id":13,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Frequent Poster","user_id":211,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Recent Poster","user_id":1,"primary_group_id":null,"flair_group_id":null},{"extras":"latest","description":"Most Recent Poster","user_id":557,"primary_group_id":null,"flair_group_id":null}]},{"fancy_title":"VDP-145 Sell $SAFE for ETH","id":1645,"title":"VDP-145 Sell $SAFE for ETH","slug":"vdp-145-sell-safe-for-eth","posts_count":4,"reply_count":1,"highest_post_number":5,"image_url":null,"created_at":"2024-04-17T13:14:44.329Z","last_posted_at":"2024-04-22T12:52:51.651Z","bumped":true,"bumped_at":"2024-04-22T12:52:51.651Z","archetype":"regular","unseen":false,"pinned":false,"unpinned":null,"visible":true,"closed":false,"archived":false,"bookmarked":null,"liked":null,"views":353,"like_count":5,"has_summary":false,"last_poster_username":"clarck7","category_id":11,"op_like_count":3,"pinned_globally":false,"featured_link":null,"has_accepted_answer":false,"posters":[{"extras":null,"description":"Original Poster","user_id":16,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Recent Poster","user_id":251,"primary_group_id":null,"flair_group_id":null},{"extras":"latest","description":"Most Recent Poster","user_id":347,"primary_group_id":null,"flair_group_id":null}]},{"fancy_title":"VDP-120 [Assessment]: Oisín Biotechnologies - Genetic Medicines for Health and Longevity","id":1432,"title":"VDP-120 [Assessment]: Oisín Biotechnologies - Genetic Medicines for Health and Longevity","slug":"vdp-120-assessment-oisin-biotechnologies-genetic-medicines-for-health-and-longevity","posts_count":16,"reply_count":9,"highest_post_number":16,"image_url":"https://europe1.discourse-cdn.com/flex017/uploads/vitadao/optimized/1X/d846a105452be0c6ac183533b8ac537f30073806_2_1024x538.jpeg","created_at":"2023-09-01T13:12:52.348Z","last_posted_at":"2024-04-18T04:22:24.948Z","bumped":true,"bumped_at":"2024-04-18T04:22:24.948Z","archetype":"regular","unseen":false,"pinned":false,"unpinned":null,"visible":true,"closed":false,"archived":false,"bookmarked":null,"liked":null,"views":1637,"like_count":28,"has_summary":false,"last_poster_username":"alanduranfire","category_id":11,"op_like_count":1,"pinned_globally":false,"featured_link":null,"has_accepted_answer":false,"posters":[{"extras":null,"description":"Original Poster","user_id":459,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Frequent Poster","user_id":211,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Frequent Poster","user_id":251,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Recent Poster","user_id":468,"primary_group_id":null,"flair_group_id":null},{"extras":"latest","description":"Most Recent Poster","user_id":680,"primary_group_id":null,"flair_group_id":null}]},{"fancy_title":"VDP-144 The Longevist Annual Review","id":1640,"title":"VDP-144 The Longevist Annual Review","slug":"vdp-144-the-longevist-annual-review","posts_count":18,"reply_count":10,"highest_post_number":18,"image_url":"https://europe1.discourse-cdn.com/flex017/uploads/vitadao/original/1X/d470a1e29f2b20d9d960e72a0a493c647d790370.png","created_at":"2024-04-08T19:53:55.444Z","last_posted_at":"2024-04-16T14:18:20.584Z","bumped":true,"bumped_at":"2024-04-16T14:18:20.584Z","archetype":"regular","unseen":false,"pinned":false,"unpinned":null,"visible":true,"closed":false,"archived":false,"bookmarked":null,"liked":null,"views":772,"like_count":24,"has_summary":false,"last_poster_username":"Rhys","category_id":11,"op_like_count":0,"pinned_globally":false,"featured_link":null,"has_accepted_answer":false,"posters":[{"extras":"latest","description":"Original Poster, Most Recent Poster","user_id":281,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Frequent Poster","user_id":654,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Frequent Poster","user_id":347,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Recent Poster","user_id":557,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Recent Poster","user_id":35,"primary_group_id":null,"flair_group_id":null}]},{"fancy_title":"VDP-143 [Funding] Fission Pharma - Revised","id":1629,"title":"VDP-143 [Funding] Fission Pharma - Revised","slug":"vdp-143-funding-fission-pharma-revised","posts_count":23,"reply_count":13,"highest_post_number":23,"image_url":"https://europe1.discourse-cdn.com/flex017/uploads/vitadao/optimized/1X/784b7c07977262c8a50b78cd19abeb53fc215daf_2_1024x541.jpeg","created_at":"2024-03-13T05:49:11.721Z","last_posted_at":"2024-04-13T11:56:24.802Z","bumped":true,"bumped_at":"2024-04-13T11:56:24.802Z","archetype":"regular","unseen":false,"pinned":false,"unpinned":null,"visible":true,"closed":false,"archived":false,"bookmarked":null,"liked":null,"views":1565,"like_count":48,"has_summary":false,"last_poster_username":"Max_Unfried","category_id":11,"op_like_count":1,"pinned_globally":false,"featured_link":null,"has_accepted_answer":false,"posters":[{"extras":null,"description":"Original Poster","user_id":181,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Frequent Poster","user_id":557,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Frequent Poster","user_id":24,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Recent Poster","user_id":294,"primary_group_id":null,"flair_group_id":null},{"extras":"latest","description":"Most Recent Poster","user_id":35,"primary_group_id":null,"flair_group_id":null}]},{"fancy_title":"VDP-142 Healthspan XPRIZE Plan","id":1621,"title":"VDP-142 Healthspan XPRIZE Plan","slug":"vdp-142-healthspan-xprize-plan","posts_count":9,"reply_count":2,"highest_post_number":9,"image_url":"https://europe1.discourse-cdn.com/flex017/uploads/vitadao/optimized/1X/1e33a854e0e5581fc8c11ec17b1b5215402acc07_2_1024x514.jpeg","created_at":"2024-03-01T23:54:12.560Z","last_posted_at":"2024-03-20T02:57:14.655Z","bumped":true,"bumped_at":"2024-03-20T02:57:14.655Z","archetype":"regular","unseen":false,"pinned":false,"unpinned":null,"visible":true,"closed":false,"archived":false,"bookmarked":null,"liked":null,"views":575,"like_count":25,"has_summary":false,"last_poster_username":"vincent","category_id":11,"op_like_count":1,"pinned_globally":false,"featured_link":null,"has_accepted_answer":false,"posters":[{"extras":null,"description":"Original Poster","user_id":459,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Frequent Poster","user_id":24,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Frequent Poster","user_id":557,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Recent Poster","user_id":654,"primary_group_id":null,"flair_group_id":null},{"extras":"latest","description":"Most Recent Poster","user_id":16,"primary_group_id":null,"flair_group_id":null}]},{"fancy_title":"VDP-139 [Funding] Luminova: mtON gene therapy in the aged eye","id":1594,"title":"VDP-139 [Funding] Luminova: mtON gene therapy in the aged eye","slug":"vdp-139-funding-luminova-mton-gene-therapy-in-the-aged-eye","posts_count":34,"reply_count":23,"highest_post_number":35,"image_url":"https://europe1.discourse-cdn.com/flex017/uploads/vitadao/original/1X/2e7185d2127b17d3c0883b48a9090e8893daec37.png","created_at":"2024-02-04T12:29:38.295Z","last_posted_at":"2024-03-05T17:51:35.809Z","bumped":true,"bumped_at":"2024-03-05T17:51:35.809Z","archetype":"regular","unseen":false,"pinned":false,"unpinned":null,"visible":true,"closed":false,"archived":false,"bookmarked":null,"liked":null,"views":1410,"like_count":53,"has_summary":false,"last_poster_username":"vincent","category_id":11,"op_like_count":1,"pinned_globally":false,"featured_link":null,"has_accepted_answer":false,"posters":[{"extras":null,"description":"Original Poster","user_id":144,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Frequent Poster","user_id":13,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Frequent Poster","user_id":659,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Recent Poster","user_id":557,"primary_group_id":null,"flair_group_id":null},{"extras":"latest","description":"Most Recent Poster","user_id":16,"primary_group_id":null,"flair_group_id":null}]}]}}